BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10629549)

  • 1. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast.
    Lakhani SR; Chaggar R; Davies S; Jones C; Collins N; Odel C; Stratton MR; O'Hare MJ
    J Pathol; 1999 Dec; 189(4):496-503. PubMed ID: 10629549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
    Moinfar F; Man YG; Arnould L; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer Res; 2000 May; 60(9):2562-6. PubMed ID: 10811140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
    Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
    Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
    Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
    Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss and the progression of breast cancer.
    Radford DM; Phillips NJ; Fair KL; Ritter JH; Holt M; Donis-Keller H
    Cancer Res; 1995 Nov; 55(22):5180-3. PubMed ID: 7585569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity in ductal carcinoma in situ of the breast.
    Stratton MR; Collins N; Lakhani SR; Sloane JP
    J Pathol; 1995 Feb; 175(2):195-201. PubMed ID: 7738715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues.
    Larson PS; Schlechter BL; de las Morenas A; Garber JE; Cupples LA; Rosenberg CL
    J Clin Oncol; 2005 Dec; 23(34):8613-9. PubMed ID: 16314623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
    Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
    Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale.
    Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Phillips KA; Campbell IG
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1396-8. PubMed ID: 16835342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
    Hampton GM; Mannermaa A; Winqvist R; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee WK; Evans GA
    Cancer Res; 1994 Sep; 54(17):4586-9. PubMed ID: 8062246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
    J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
    Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème MH; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen AM; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale AL
    Genes Chromosomes Cancer; 1999 Jul; 25(3):212-21. PubMed ID: 10379867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
    Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
    J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.